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Signal transduction is regulated by the lateral segregation of proteins into nanodomains on the plasma
membrane. However, the molecular mechanisms that regulate the lateral segregation of cell surface receptors,
such as receptor tyrosine kinases, upon ligand binding are unresolved. Here we used high-resolution spatial
mapping to investigate the plasma membrane nanoscale organization of the epidermal growth factor (EGF)
receptor (EGFR). Our data demonstrate that in serum-starved cells, the EGFR exists in preformed, choles-
terol-dependent, actin-independent nanoclusters. Following stimulation with EGF, the number and size of
EGFR nanoclusters increase in a time-dependent manner. Our data show that the formation of EGFR
nanoclusters requires receptor tyrosine kinase activity. Critically, we show for the first time that production of
phosphatidic acid by phospholipase D2 (PLD2) is essential for ligand-induced EGFR nanocluster formation.
In accordance with its crucial role in regulating EGFR nanocluster formation, we demonstrate that modulating
PLD2 activity tunes the degree of EGFR nanocluster formation and mitogen-activated protein kinase signal
output. Together, these data show that EGFR activation drives the formation of signaling domains by regu-
lating the production of critical second-messenger lipids and modifying the local membrane lipid environment.
The epidermal growth factor (EGF) receptor (EGFR) is a
single transmembrane domain protein that possesses intrinsic
tyrosine kinase (TK) activity. Ligand binding to the extracel-
lular domain induces conformational changes that promote
activation of the intracellular TK domain. The kinase domain
then autophosphorylates a number of tyrosine residues in the
C-terminal region of the protein, creating docking sites for
adapter and effector proteins. Thus, the active form of the
EGFR could reasonably be expected to be a dimer. However,
recent studies using single-molecule imaging, image correla-
tion spectroscopy (ICS), fluorescence correlation spectroscopy
(FCS), and immunoelectron microscopy (immuno-EM) show
that the EGFR is, in fact, nonrandomly organized into oligo-
mers on the plasma membrane (6, 7, 16, 34, 44). ICS measure-
ments estimate that, in the absence of ligand, there are, on
average, 2.2 EGFRs per cluster, which increases to 3.7 recep-
tors per cluster upon stimulation (7). Single-molecule tracking
experiments also suggest that unliganded EGFRs continually
fluctuate between monomers and dimers that are primed for
activation (5). Furthermore, the organization of the EGFR is
dynamic and clustering of the EGFR increases over time after
EGF stimulation (7, 16). However, neither the precise role of
EGFR oligomerization in signal transduction nor the mecha-
nisms driving oligomer formation have been resolved.
The organization of the EGFR into oligomers is dependent
upon cellular cholesterol. Saffarian et al., using FCS, estimated
that 70% of EGFRs exist as monomers, 20% as dimers, and
10% as oligomers (34). However, depletion of cholesterol de-
creases the percentage of monomeric receptors and increases
the proportion of oligomeric receptors. Cholesterol depletion
and actin depolymerization also alter the diffusion coefficient
of the EGFR and the confinement area size (22). The finding
that EGFR membrane organization is dependent upon cho-
lesterol is of particular interest because a number of studies
have demonstrated that EGFR activity is negatively regulated
by cholesterol (4, 23, 28, 32).
Phospholipase D2 (PLD2) hydrolyzes phosphatidylcholine
(PC) to produce choline and phosphatidic acid (PA). PLD2 is
localized to the plasma membrane (10), associates with the
EGFR (39), and is rapidly activated upon EGF stimulation,
leading to increased production of PA (15, 38, 39). A number
of lines of evidence suggest that PA is an important mediator
of EGFR action. First, exogenous PA is mitogenic when incu-
bated with cells (17, 19, 42, 45). Second, direct interaction with
membrane PA regulates the activity of a number of compo-
nents downstream of the EGFR, including Sos (47) and Raf
(12, 13, 30, 31).
In the current study, we used high-resolution spatial analysis
techniques to investigate EGFR plasma membrane organiza-
tion. Using these approaches, we identified PA as the key
molecular component responsible for driving EGFR nanoclus-
ter formation in response to EGF binding and demonstrated
that the level of PLD2 activity regulates the duration of mito-
gen-activated protein kinase (MAPK) signal output.
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MATERIALS AND METHODS
Cell culture. Baby hamster kidney (BHK) cells were maintained in HEPES-
buffered Dulbecco’s modified Eagle’s medium containing 10% heat-inactivated
serum supreme (Lonza, Basel, Switzerland). BHK cells were seeded onto either
13-mm glass coverslips for EM and confocal microscopy or 6-cm dishes for
biochemical assays and transfected using Lipofectamine reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions as previously de-
scribed (33). Where indicated, cells were serum starved for approximately 4 h
and then treated with 50 ng/ml EGF (Sigma-Aldrich, St. Louis, MO), 100 M
phosphatic acid (1,2-dipalmitoyl-sn-glycero-3-phosphate sodium salt; Sigma-Al-
drich, St. Louis, MO), 100 M phosphatidylserine (1,2-dipalmitoyl-sn-glycero-3-
phospho-L-serine sodium salt; Sigma-Aldrich, St. Louis, MO), diacylglycerol
(DAG) kinase inhibitor II (R59949; EMD Biosciences), or ()-propranolol
hydrochloride (Sigma-Aldrich, St. Louis, MO) for the indicated times.
Plasmids. The yeast soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE) protein Spo20p PA binding domain, described pre-
viously (46), was subcloned into a vector containing monomeric red fluorescent
protein (mRFP). To increase the cytoplasmic pool of the fusion protein, a
nuclear export sequence (NES) was also added.
Western blotting. Cells were washed and subjected to detergent lysis. For
analysis of signal transduction, whole-cell lysates were produced (50 mM Tris
[pH 7.5], 75 mM NaCl, 25 mM NaF, 5 mM MgCl2, 5 mM EGTA, 1 mM
dithiothreitol, 100 M NaVO4, 1% Nonidet P-40 plus protease inhibitors) and a
total of 20 g of each was immunoblotted with anti-pERK antibody (Cell Sig-
naling Technologies, Danvers, MA). Anti--actin and --tubulin antibodies were
used as loading controls. Signal was detected by enhanced chemiluminescence
(SuperSignal; Pierce, Thermo Fisher Scientific, Rockford, IL) and imaged by
FluorChemQ (Alpha Innotech, San Leandro, CA). Quantification of intensities
was performed using FluorChemQ software.
PLD activity assay. PLD activity was measured by transphosphatidylation
reaction. BHK cells grown in 35-mm dishes were labeled overnight with
[3H]palmitic acid. Cells were serum starved and then incubated with 0.3% 1-bu-
tanol in the presence or absence of 50 ng/ml EGF. The reaction was stopped by
the addition of cold methanol.
EM and statistical analysis. Plasma membrane sheets were prepared, fixed,
and labeled with affinity-purified anti-GFP (green fluorescent protein) antiserum
coupled directly to 5-nm gold particles as described previously (14, 25). Digital
images of the immunogold-labeled plasma membrane sheets were taken in a
transmission electron microscope (JEOL 1011; JEOL, Tokyo, Japan). Intact
1-m2 areas of the plasma membrane sheet were identified using ImageJ, and
the x-y coordinates of the gold particles were determined as described previously
(14, 25). Ripley’s K function (2, 29) was calculated using the x-y coordinates and
then standardized on the 99% confidence interval (CI) for a random pattern (14,
25). Bootstrap tests to examine differences between replicated point patterns
were constructed exactly as described previously (9), and statistical significance
was evaluated against 1,000 bootstrap samples.
Analysis of endogenous EGFR nanoclusters was performed as described
above but with the following changes. The EGFR was detected using an anti-
EGFR antibody (Cell Signaling Technologies, Danvers, MA) and a goat anti-
rabbit secondary antibody conjugated to 5-nm gold particles (BB International,
Cardiff, United Kingdom).
Confocal microscopy. BHK cells grown on 13-mm glass coverslips were fixed
using 4% paraformaldehyde and imaged using a Zeiss LSM 510 confocal micro-
scope (Carl Zeiss, Thornwood, NY) with the appropriate GFP filter set.
Fluorescence lifetime imaging-fluorescence resonance energy transfer (FLIM-
FRET) microscopy. FLIM-FRET experiments were carried out using a lifetime
fluorescence imaging attachment (Lambert Instruments, Leutingewolde, Neth-
erlands) on an inverted microscope (Eclipse Ti; Nikon Instruments Inc.,
Melville, NY). BHK cells transiently expressing EGFR-GFP (donor), alone or
with mRFP-NES Spo20p (acceptor) (using a 1:2 ratio of plasmid DNA), were
serum starved, treated with 50 ng/ml EGF for the indicated times, and then fixed
using 4% paraformaldehyde. The samples were excited using a sinusoidally
modulated 3-W 470-nm light-emitting diode at 40 MHz under epi-illumination.
Fluorescein was used as a lifetime reference standard. Cells were imaged with a
Plan Apo 60 1.40 oil objective using an appropriate GFP filter set. The phase
and modulation were determined from a set of 12 phase settings using the
manufacturer’s software. Analysis was performed on a cell-by-cell basis.
RESULTS
The EGFR is organized into nanoclusters on the plasma
membrane. The spatial organization of the EGFR was exam-
ined in BHK cells in the absence of serum. In order to analyze
the intracellular organization, we used an EGFR-GFP fusion
construct in which GFP was used to tag the C terminus of the
EGFR. Plasma membrane sheets were generated from cells
expressing EGFR-GFP and labeled with anti-GFP antibody
conjugated directly to 5-nm gold particles. Spatial analysis
demonstrated that in the absence of serum, 32%  1.9%
(standard error of the mean [SEM]; n  15) of the EGFRs
exist as monomers and 67%  1.9% (SEM; n  15) of the
EGFRs were organized into nanoclusters ranging from dimers
to high-order oligomers that had an average radius of 24 nm
(Fig. 1A). We detected an average of 2.3 gold particles per
cluster. Accounting for the previously characterized capture
ratio of the anti-GFP antibody (24), we estimated that the
upper range of EGFR proteins per nanocluster was about six.
For the frequency distribution of cluster size, see Fig. S1A in
the supplemental material. Next, we analyzed whether the level
of EGFR-GFP expression affected the degree of nanocluster-
FIG. 1. The EGFR is organized into nanoclusters on the plasma
membrane. (A) Plasma membrane sheets generated from BHK cells
expressing EGFR-GFP were labeled with anti-GFP antibody conju-
gated to 5-nm gold particles. The spatial distribution of the gold la-
beling was analyzed using Ripley’s K function. Maximum L(r)  r values
above the 99% CI for complete spatial randomness indicate clustering at
the value of r (supr). Univariate K functions are weighted means (n 15)
standardized on the 99% CI. (B) BHK cells expressing EGFR-GFP were
left untreated or treated with either 1% methyl--cyclodextrin for 60 min
or 1 M latrunculin A for 5 min. Plasma membrane sheets were labeled
with anti-GFP antibody conjugated to 5-nm gold particles. Univariate K
functions are weighted means (n  6) standardized on the 99% CI.
Significant differences from the control EGFR pattern were assessed
using bootstrap tests. Treatment with latrunculin A did not signifi-
cantly alter EGFR nanocluster formation (P 1). However, treatment
with methyl--cyclodextrin significantly decreased EGFR nanocluster-
ing (P  0.001).
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ing detected in these experiments. We found that there was no
significant correlation between EGFR-GFP plasma membrane
expression and the degree of nanocluster formation detected
(see Fig. S1B in the supplemental material). Finally, we con-
firmed that endogenous EGFR was organized into similar
nanoclusters in A431 cells by using an anti-EGFR primary
antibody detected by a secondary antibody conjugated to 5-nm
gold particles (see Fig. S2A in the supplemental material).
To determine the membrane components required to main-
tain EGFR nanoclusters in the absence of serum, we treated
serum-starved cells expressing EGFR-GFP with either methyl-
-cyclodextrin to deplete cellular cholesterol or latrunculin A
to depolymerize the actin cytoskeleton. Plasma membrane
sheets derived from these cells were immunogold labeled with
anti-GFP antibody. Spatial analysis of the resulting gold pat-
tern demonstrated that depletion of cellular cholesterol signif-
icantly decreased EGFR nanoclustering (Fig. 1B). However,
treatment with latrunculin A did not have a significant effect
(Fig. 1B).
EGFR nanocluster formation is regulated by EGF. Next, we
investigated whether the formation of EGFR nanoclusters is
functionally relevant to EGF-induced signal transduction. We
stimulated serum-starved BHK cells expressing EGFR-GFP
with EGF and examined the spatial organization of the EGFR
over time. We observed a significant increase in EGFR nano-
cluster formation after EGF stimulation (Fig. 2A). The highest
levels of EGFR nanoclustering were detected following 10 to
20 min of EGF treatment. These data suggested that EGFR
nanocluster formation occurred in response to receptor acti-
vation. A similar increase in EGFR nanoclustering upon EGF
stimulation was also detected in HEK 293 cells expressing
EGFR-GFP (see Fig. S2B in the supplemental material). Dur-
ing the course of this analysis, we noticed that the radius of the
EGFR nanoclusters increased upon ligand stimulation. Our
analysis demonstrated that following EGF stimulation for 20
min, the average radius of an EGFR nanocluster had increased
to 30 nm. The percentage of EGFR in clusters had also in-
creased from 67%  1.9% (SEM; n  15) to 83%  2.1%
(SEM; n  12). The percentage of monomers decreased from
32% to 17%, and the percentage of receptors present in
high-order oligomers increased. For the frequency distribution
of cluster size, see Fig. S1B in the supplemental material.
EGFR nanoclusters had 3.4 gold particles per cluster. Ac-
counting for the anti-GFP antibody capture ratio, we estimated
that there could be as many as nine proteins per cluster fol-
lowing EGF stimulation.
Following activation, EGFR undergoes endocytosis, leading
to the downregulation of receptor activity. Therefore, we in-
vestigated how EGFR nanoclustering is regulated over longer
time periods. Cells expressing EGFR-GFP were serum starved
and then stimulated with EGF for up to 60 min. Using spatial
analysis, we found that the level of EGFR nanoclustering had
returned to basal levels after 40 min of EGF stimulation (Fig.
2B). The EGFR is known to be clustered in clathrin-coated
pits following ligand binding. Therefore, it was conceivable
that the increased formation of EGFR nanoclusters, in re-
sponse to ligand binding, occurred as a consequence of clath-
rin-coated pit formation. However, while we were able to de-
tect the clustering of EGFR into clathrin-coated pits by our
immuno-EM technique, we were also able to detect a signifi-
cant proportion of EGFR nanoclusters that existed in morpho-
logically smooth regions of the plasma membrane (see Fig. S3
in the supplemental material). These data suggest that clath-
rin-coated pit formation is not a prerequisite for EGFR nano-
cluster formation and that additional mechanisms may also
regulate EGFR nanocluster formation.
EGFR nanocluster formation is dependent on receptor TK
(RTK) activity. To determine directly whether EGFR nano-
cluster formation requires RTK activity, we utilized the TK
inhibitor AG1478. Treatment with 100 nM AG1478 was suffi-
cient to inhibit the production of ppERK in response to EGF
stimulation (Fig. 3A). Spatial analysis of plasma membrane
sheets generated under the same conditions demonstrated that
cells treated with AG1478 had a lower basal level of EGFR
nanoclustering than control untreated cells (Fig. 3B). Impor-
tantly, our data also demonstrated that EGF stimulation failed
to induce EGFR nanoclustering in those cells that had been
pretreated with AG1478 (Fig. 3B). Together, these data dem-
onstrate that formation of EGFR nanoclusters in response to
EGF requires RTK activity.
FIG. 2. EGFR nanocluster formation is induced by EGF stimula-
tion. BHK cells expressing EGFR-GFP were serum starved and then
stimulated with 50 ng/ml EGF for the indicated times. Plasma mem-
brane sheets were labeled with anti-GFP antibody conjugated to 5-nm
gold particles. Univariate K functions are weighted means (n  10)
standardized on the 99% CI. Significant differences from the control
unstimulated EGFR pattern were assessed using bootstrap tests.
(A) Stimulation with EGF resulted in a significant increase in EGFR
nanocluster formation at all time points (P  0.001). (B) Stimulation
with EGF for 10 and 20 min led to a significant increase in EGFR
nanoclustering compared to that obtained with the unstimulated
control (P  0.003 and P  0.001, respectively). However, EGFR
nanoclustering was not significantly different from unstimulated
EGFR nanoclustering following stimulation with EGF for 40 and 60
min (both P  1).
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PLD2 activity regulates EGFR nanocluster formation. The
data in Fig. 3 suggest that formation of EGFR nanoclusters
requires RTK activity. Therefore, we examined what factors
immediately downstream of RTK activation are involved in
regulating EGFR nanocluster formation. PLD2 converts PC
into PA by removal of the bulky choline head group and is
activated by EGFR TK activity (18, 39). We confirmed that
PLD activity was increased upon EGF stimulation (Fig. 4) and
that PLD2 was localized to the plasma membrane in BHK cells
(data not shown). To determine whether PLD2 lipase activity
is necessary for the formation of EGFR nanoclusters, we uti-
lized the PLD2 K758R mutant that is deficient in lipase activity
and acts in a dominant interfering manner (40, 41). Cells ex-
pressing EGFR-GFP alone or in the presence of PLD2 K758R
were serum starved and then stimulated with EGF for 10 min.
Expression of PLD2 K758R significantly decreased the basal
level of EGFR nanoclustering detected in unstimulated cells
(Fig. 5A) in a manner similar to that of treatment with the TK
inhibitor AG1478 (Fig. 3B). Stimulation with EGF resulted in
a significant increase in the number of EGFR nanoclusters in
cells expressing EGFR-GFP alone. However, in cells coex-
pressing EGFR-GFP and PLD2 K758R, EGF stimulation led
to only a small increase in EGFR nanocluster formation that
did not reach basal levels (Fig. 5A). In contrast, the expression
of dominant negative PLD1 (PLD1 K898R) did not decrease
the basal level of EGFR nanoclustering, and upon EGF stim-
ulation, the levels of EGFR nanoclustering were similar in the
presence and absence of PLD1 K898R (data not shown). We
analyzed the effect of PLD2 K758R on EGFR signal transduc-
tion and found that expression of PLD2 K758R significantly
reduced ppERK production in response to EGF (Fig. 5D).
These data suggest that PLD2 activity is required for stimulus-
dependent EGFR nanocluster formation and consequently sig-
nal output.
PA can be converted into DAG through the action of PA
phosphohydrolase (PAP) (3). Propranolol, a -adrenergic re-
ceptor antagonist, can inhibit PAP activity when used at high
concentrations. Incubation with a high dose of propranolol
(200 M) is sufficient to elevate cellular PA levels, with a
maximal increase detected following 30 min of treatment
(21). Therefore, we investigated whether the production of PA
or its subsequent conversion into DAG is important for EGFR
nanoclustering. Serum-starved cells expressing EGFR-GFP
were treated with 200 M propranolol, and plasma membrane
sheets were generated. Spatial analysis demonstrated that pro-
pranolol treatment led to an increase in the basal level of
EGFR nanocluster formation (Fig. 5B). These data suggested
that the increased level of PA, through the inhibition of PAP
activity, was sufficient to promote EGFR nanoclustering in the
absence of a stimulus. It was important to confirm that pro-
pranolol was mediating its effect on EGFR nanoclustering via
inhibition of PAP activity and not through antagonism of
FIG. 3. Induction of EGFR nanoclustering following ligand bind-
ing requires RTK activity. (A) BHK cells were serum starved and then
pretreated with 100 nM AG1478 for 10 min as indicated, followed by
EGF stimulation in the presence or absence of AG1478 for 10 min as
indicated. Whole-cell lysates were generated, and 20 g of lysate was
blotted for ppERK. Actin was used as a loading control. The graph
represents the mean of three independent experiments (SEM). Rep-
resentative blots are shown. (B) BHK cells expressing EGFR-GFP
were serum starved and treated with AG1478 for 10 min as indicated
prior to stimulation with 50 ng/ml EGF for 10 min. Plasma membrane
sheets were labeled with anti-GFP antibody conjugated to 5-nm gold
particles. Univariate K functions are weighted means (n  13) stan-
dardized on the 99% CI. Significant differences from the control un-
stimulated EGFR pattern were assessed using bootstrap tests. Treat-
ment with AG1478 led to a significant reduction in EGFR
nanoclustering in the presence and absence of EGF (both P  0.001).
FIG. 4. PLD activity is elevated by EGF. BHK cells were serum
starved and then stimulated with EGF for 1 min, and the production of
phosphatidylbutanol was measured. Bars represent the relative pro-
portion of phosphatidylbutanol to total lipid (n  4)  the standard
deviation. Statistical significance was determined by t test (, P 
0.002). The graph is representative of four independent experiments.
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-adrenergic receptor activity. To investigate this possibility,
we examined the effect of lower doses of propranolol on
EGFR nanoclustering. Our data demonstrate that basal nano-
clustering of EGFR is not altered by treatment with 2 M and
20 M propranolol, doses that are sufficient to completely
block -adrenergic receptor activity (see Fig. S4 in the supple-
mental material). These data suggest that the elevated nano-
clustering detected following treatment with 200 M propran-
olol is indeed due to the specific function of propranolol as a
PAP inhibitor. Thus, inhibiting the conversion of PA to DAG
does not inhibit EGFR nanoclustering. Interestingly, treat-
ment with a high dose of propranolol led to a small increase in
ppERK production in serum-starved cells (Fig. 5E), consistent
with increased EGFR nanoclustering.
FIG. 5. PLD2 activity is required for ligand-induced EGFR nanocluster formation. BHK cells expressing EGFR-GFP alone (B and C) or in
combination with PLD2 K758R (A) were serum starved and treated as follows: (A) 50 ng/ml EGF for 10 min where indicated, (B) 200 M
propranolol for 30 min, followed by 50 ng/ml EGF for 10 min where indicated (C), or 50 ng/ml EGF for 10 min in the presence or absence of 1
M R59949 where indicated. Plasma membrane sheets were generated and labeled with anti-GFP antibody conjugated to 5-nm gold particles.
Univariate K functions are weighted means (n  6) standardized on the 99% CI. Significant differences from the control unstimulated EGFR
pattern were assessed using bootstrap tests. (A) Expression of PLD2 K758R significantly decreased the basal level of EGFR nanoclustering (P 
0.001). (B) Treatment with 200 M propranolol led to a significant increase in EGFR nanocluster formation (P 0.001). (D and E) Whole lysates
were extracted from cells treated as indicated for panels A and B, and 20 g of each lysate was blotted for ppERK. Actin was used as a loading
control. The graphs represent the mean of three independent experiments (SEM). Significant differences from the control were assessed by t test.
(D) The expression of PLD2 K758R led to a significant reduction in ppERK following EGF stimulation compared to those cells expressing EGFR
alone (, P  0.02). (E) Treatment with 200 M propranolol in the absence of EGF increased basal ppERK levels, although the increase did not
reach significance (P  0.2).
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PA can also be generated from DAG via the action of the
DAG kinase (DGK). To determine whether the production of
PA by DGK is also important for EGFR nanocluster forma-
tion in response to EGF, we stimulated cells with EGF in the
presence or absence of R59949, a specific DGK inhibitor. In
the presence of R59949, there was a slight reduction in basal
EGFR nanoclustering in serum-starved cells. However, treat-
ment with R59949 did not inhibit EGF-stimulated nanocluster
formation (Fig. 5C). These data suggest that PA production by
DGK has only a minor role in regulating EGFR nanocluster
formation.
EGF stimulation generates PA production in EGFR nano-
clusters. To confirm that PA was produced in a spatially rele-
vant manner, we analyzed PA production in response to EGF
by means of a GFP-tagged PA binding probe (PA binding
domain of Spo20p) described previously (46). In cells that had
been serum starved, the PA binding probe was predominantly
cytosolic (Fig. 6A). However, following EGF stimulation, we
detected a significant enrichment of GFP fluorescence at the
plasma membrane. Membrane recruitment of GFP-Spo20p
was detected after as little as 1 min of EGF stimulation (Fig.
6A). GFP-Spo20p plasma membrane recruitment was also de-
FIG. 6. EGF stimulates PA production at the plasma membrane. (A) BHK cells expressing GFP NES Spo20p were serum starved and then
stimulated with 50 ng/ml EGF. Cells were fixed and imaged by confocal microscopy. (B) Plasma membrane sheets were generated from BHK cells
expressing GFP NES Spo20p that had been serum starved and then stimulated with EGF for the indicated times. Plasma membrane sheets were
labeled with anti-GFP antibody conjugated to 5-nm gold particles. (Left panel) The L(r)  r curve represents the clustering of GFP NES Spo20p
after 10 min of EGF stimulation. (Right panel) The graph represents the mean number of gold particles/m2 (SEM). (C) BHK cells expressing
EGFR-GFP alone or in combination with mRFP NES Spo20p were serum starved and then stimulated with 50 ng/ml EGF for the indicated times.
Cells were imaged in the frequency domain using a wide-field FLIM-FRET microscope. Data points represent the mean fluorescence lifetime of
GFP (SEM). The green dashed line represents the lifetime of EGFR-GFP in the absence of mRFP NES Spo20p. Representative fluorescence
lifetime images are shown.
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tected by immuno-EM. Spatial analysis demonstrated that the
PA probe was organized into nanoclusters on the plasma mem-
brane following 10 min of EGF stimulation (Fig. 6B). To
confirm that the production of PA was localized to EGFR
nanoclusters, we performed FLIM-FRET experiments with
cells expressing EGFR-GFP (donor) alone or in the presence
of mRFP NES Spo20p (acceptor). The cells were serum
starved and then stimulated with EGF, and changes in the
fluorescent lifetime of the GFP fluorophore were measured.
Stimulation with EGF led to a rapid and significant reduction
in the fluorescent lifetime of GFP, indicating that the PA
probe was recruited to the EGFR nanoclusters over the same
time course in which increased EGFR nanoclustering was de-
tected (Fig. 6C).
PA directly regulates EGFR nanocluster formation. To
demonstrate that PA was the critical mediator of EGFR nano-
cluster formation, we investigated whether addition of exoge-
nous PA is sufficient to stimulate EGFR nanocluster forma-
tion. BHK cells expressing EGFR-GFP were serum starved
and then incubated with PA over a time course. Spatial analysis
revealed that treatment with PA alone was sufficient to in-
crease EGFR nanoclustering over the same time course as
EGF stimulation (Fig. 7A). We detected a similar increase in
EGFR nanoclustering upon PA stimulation in HEK 293 cells
expressing EGFR-GFP (see Fig. S2B in the supplemental ma-
terial).
In control experiments, treatment of cells with exogenous PS
did not alter EGFR nanocluster formation (Fig. 7B). There-
fore, we conclude that the increased EGFR nanoclustering was
specific to the action of exogenous PA and not a consequence
of perturbing the plasma membrane in general.
PA regulates EGFR nanocluster formation downstream of
RTK activity. The data in Fig. 1 to 7 demonstrate that upon
ligand binding, the EGFR promotes the activation of PLD2,
resulting in an increase in the local concentration of PA that
induces EGFR nanocluster formation. Based on these data, we
hypothesized that if production of PA was the critical factor
required for EGFR nanocluster formation, the inhibition of
RTK activity would not impede the ability of exogenous PA to
induce EGFR nanocluster formation. To address this hypoth-
esis, we pretreated cells expressing EGFR-GFP with the TK
inhibitor AG1478 and then incubated them with PA. Figure
8A shows that stimulation with PA in the presence of AG1478
led to a substantial increase in EGFR nanoclustering. Indeed,
the level of EGFR nanocluster formation was similar to that
induced by treatment with PA in the absence of AG1478.
Taken together, these data suggest that PA is a potent regu-
lator of EGFR spatial organization and acts downstream of
RTK activation.
Our data suggest that the production of PA via the action of
PLD2 promotes the formation of EGFR nanoclusters. We next
asked how prolonged production of PA would affect the long-
term regulation of EGFR nanocluster formation. Serum-
starved BHK cells that expressed EGFR-GFP alone or in the
presence of PLD2 were stimulated with EGF. Figure 8B shows
that in cells expressing EGFR-GFP alone, EGFR nanocluster-
ing returned to basal levels after 60 min of EGF stimulation. In
contrast, overexpression of PLD2 maintained a high level of
EGFR nanoclustering after 60 min of EGF stimulation (Fig.
8B). A similar prolongation of EGFR nanoclustering was ob-
served in cells cotreated with EGF and PA (Fig. 8C). These
results suggest that the continued production of PA by PLD2
is required to maintain EGFR nanoclusters.
PLD2 modulates signal output in response to EGF. Since
EGFR nanocluster formation is sustained in cells overexpress-
ing PLD2, we examined the impact of altering PLD2 activity
on EGF-induced MAPK output. Figure 9 shows that ectopic
expression of PLD2 changes the time course of ppERK gen-
eration in response to EGF. The peak response to EGF was
detected earlier, and there was sustained signal output at later
time points.
DISCUSSION
The data presented herein show that in quiescent cells a
large percentage of EGFRs are organized into nanoclusters
that range is size from dimers to higher-order oligomers and
have an average radius of24 nm. Our finding that the EGFR
is organized into oligomers on the plasma membrane is con-
sistent with previous studies using other high-resolution imag-
ing techniques (7, 16). Here we extend these studies and show
for the first time that EGFR nanocluster formation, in re-
FIG. 7. EGFR nanocluster formation is induced by treatment with
exogenous PA but not PS. BHK cells expressing EGFR-GFP were
serum starved and then stimulated with either (A) 100 M PA or
(B) 100 M PS for the indicated times. Plasma membrane sheets were
labeled with anti-GFP antibody conjugated to 5-nm gold particles.
Univariate K functions are weighted means (n  14) standardized on
the 99% CI. Significant differences from the control unstimulated
EGFR pattern were assessed using bootstrap tests. (A) Treatment with
PA led to a significant increase in EGFR nanoclustering at all time
points (P  0.001). (B) Incubation with PS did not have a significant
impact on EGFR nanoclustering over time.
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sponse to ligand binding, is driven by receptor activation and
downstream second-messenger lipid production by PLD2.
In quiescent cells, the EGFR resides in cholesterol-depen-
dent nanoclusters. However, our data suggest that following
ligand binding, the lipid properties of the EGFR nanocluster
change. We propose the following model to describe EGF-
induced EGFR nanocluster formation. Ligand binding to the
EGFR induces dimerization and activation of the TK domain.
The TK domain then autophosphorylates a number of tyrosine
residues, which act as docking sites for downstream adaptors
and effectors. PLD2 is activated by the EGFR, leading to the
hydrolysis of plasma membrane PC to produce PA and cho-
line, resulting in the production of a localized patch of mem-
brane enriched in PA. The production of PA may also be
facilitated by the conversion of DAG to PA by DGK. The
number of receptors within a cluster increases to about nine
upon ligand binding. It is possible that PA promotes the re-
cruitment of additional receptors to the nanocluster or, alter-
natively, stabilizes the interaction of receptors within the nano-
cluster. The precise molecular mechanism by which PA drives
EGFR nanocluster formation is unclear. However, the jux-
tamembrane domain of the EGFR (residues 645 to 682) con-
tains a cluster of basic residues that bind to acidic lipids in the
FIG. 8. PA production regulates EGFR nanoclustering downstream of RTK activation. (A) BHK cells expressing EGFR-GFP were serum
starved and treated with 100 nM AG1478 for 10 min as indicated prior to stimulation with 100 M PA for 10 min. (B) BHK cells expressing
EGFR-GFP in the presence or absence of PLD2 were serum starved and then stimulated with 50 ng/ml EGF for the indicated times. (C) BHK
cells expressing EGFR-GFP were serum starved and then stimulated with 50 ng/ml EGF in combination with 100 M PA for the indicated time.
Plasma membrane sheets were generated and labeled with anti-GFP antibody conjugated to 5-nm gold particles. Univariate K functions are
weighted means (n  9) standardized on the 99% CI. Significant differences from the control unstimulated EGF receptor pattern were assessed
using bootstrap tests. (A) Treatment with AG1478 led to a significant reduction in EGFR nanoclustering (P  0.041). However, cotreatment with
PA reversed the effect of AG1478 treatment, leading to a level of EGFR nanoclustering that was not significantly different from that obtained by
treatment with PA alone (P  0.961).
FIG. 9. PLD2 modulates EGF-induced signal transduction. BHK
cells expressing EGFR-GFP in the presence or absence of PLD2 were
serum starved and then stimulated with 50 ng/ml EGF for the indi-
cated times. Whole-cell lysates were subjected to sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis and Western blotting for
ppERK and -tubulin. A representative blot is shown. Bars represent
the mean fold increase in ppERK compared to control unstimulated
cells ( SEM; n  3).
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plasma membrane via electrostatic interactions (20, 35, 37).
There is evidence from studies on KcsA, a bacterial potassium
channel, that interaction with PA can stabilize protein struc-
ture and regulate function (8, 26). Therefore, we speculate that
following receptor activation, the basic residues of the jux-
tamembrane domain interact with newly generated PA, form-
ing a proteo-lipid complex. In this respect, the formation of the
EGFR nanocluster shares similarities with the mechanistic
properties underlying the formation of Ras nanoclusters (1).
Therefore, we propose that these proteo-lipid complexes form
the individual units of the EGFR nanocluster.
The organization of EGFR into PA-enriched nanoclusters
has important implications for signal transmission. First, a
number of studies have demonstrated lateral propagation of
receptor activation upon ligand binding (16, 27, 36, 43). These
studies suggest that the active EGFR dimer is transient, and
following dissociation, the active receptor is able to interact
with and activate additional EGFR proteins that are not bound
by ligand. Thus, the organization of the EGFR into nanoclus-
ters will facilitate the activation of unliganded receptors within
the cluster. Furthermore, diffusion of receptors into and out of
clusters will enhance signal propagation across the plasma
membrane.
Second, the localized patch of PA will facilitate the recruit-
ment of a number of proteins involved in MAPK pathway
activation. Specifically, the guanine nucleotide exchange factor
Sos is recruited to the plasma membrane via a PA binding
domain (47). Sos stimulates GTP loading of Ras, which re-
cruits Raf-1 from the cytosol to the plasma membrane via
interaction with the Ras binding domain of Raf-1, but once
Raf-1 is at the plasma membrane, its activity is regulated via
interaction with PS and PA (12, 13). Taken together, the data
suggest that EGFR activation stimulates the formation of an
autonomous lipid-based signaling domain that is designed to
selectively recruit a set of specific signaling molecules.
The activation of PLD2 and production of PA in response to
EGF may serve yet a third purpose in regulating EGFR func-
tion. PLD2 has a role in regulating EGFR endocytosis and
signal output via the MAPK pathway (38). The conical shape
of PA favors negative membrane curvature, and thus the gen-
eration of a patch of PA may promote endocytic vesicle for-
mation and facilitate EGFR endocytosis via the clathrin-me-
diated endocytic pathway. However, our EM data show that
EGFR nanoclusters do not require preexisting clathrin-coated
pits in order to assemble. Therefore, we speculate that the
formation of clathrin-coated pits may occur as a consequence
of EGFR nanocluster formation.
We have demonstrated that EGFR nanoclusters are tran-
sient and stimulated by ligand binding. Furthermore, EGFR
nanocluster dynamics are critically linked to the duration and
magnitude of EGF-induced signal transduction. A key param-
eter here is PLD2 activity, which is closely linked to EGFR
clustering. This is a particularly intriguing observation, since
PLD2 is overexpressed in some human tumors (11). Although
PLD2 overexpression per se is not sufficient to increase EGFR
nanoclustering, following EGF stimulation, overexpression of
PLD2 prevents EGFR nanocluster levels from returning to the
basal state and increases EGFR signal output. In human tu-
mors, overexpression of PLD2 may therefore lead to increased
signal transduction via the Ras/Raf/MEK/ERK pathway, at
least in part, by maintaining inappropriately high levels of
EGFR nanoclustering.
In summary, we show a novel role for PA in promoting
nanoclustering of a transmembrane TK receptor. Generation
of PA occurs in the immediate vicinity of the activated EGFR
as a result of activation of PLD2, leading to local remodeling
of the lipid bilayer. The generation of autonomous lipid based
signaling platforms may represent a general principle for li-
gand-induced signal transduction via cell surface RTKs.
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